Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Phase 2 Study

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis

Neoplasm Metastasis

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Urinary Bladder Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Nasopharyngeal Carcinoma

Neoplasm Metastasis

Pancreatic Adenocarcinoma

Resectable Intrahepatic Cholangiocarcinoma

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Cholangiocarcinoma

Lymphoma, Large B-Cell, Diffuse

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Breast Neoplasms

Advanced Biliary Tract Carcinoma

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Endometrial Neoplasms

Metastatic Urothelial Cancer

Breast Neoplasms

Urinary Bladder Neoplasms

Advanced Solid Tumour

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Lung Neoplasms

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms

Hodgkin Disease

Pancreatic Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Muscle Invasive Bladder Cancer (MIBC)

Carcinoma, Non-Small-Cell Lung

Pancreatic cancer, adult, Pancreatic Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

IMGeS

ASPEN-09-03

LIGHT

SWITCH

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery

IMMUNOLIFE2

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

MK-3475-01E

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

CAMPFIRE

TACTIC

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

ISG-ARTICLE

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

TROPHY U-01

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

PANCREAS

Intravesical Gem/Doce in Patients With NMIBC

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

DVDMS

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

MAGNATE-S

A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

PANC

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

HARBOR

ctDNA Lung RCT

ACPC